RxDoctor Payments Data

Paige Kight, APRN

Adult Health · Columbia, SCNPI 1538661269

Payments from drug & device makers

$924in general payments, 2019–2025

Across 50 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$223
  • Lilly USA, LLC$119
  • AbbVie$80
  • Amgen$63
  • AstraZeneca$57
  • Dexcom, Inc.$55
  • plus $328 from 14 others

What the payments were for

  • Food & beverage$91399%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$924 in reported general payments places this provider in the 50th percentile of 292 adult health providers in South Carolina.

See all adult health providers in South Carolina

Medicare billing

Part B allowed, 2024
$87,378
Medicare patients
213
Services billed
1,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$138,922
JardianceEmpagliflozin44$63,579
FarxigaDapagliflozin Propanediol32$46,085
TrulicityDulaglutide18$39,121
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$37,566
VraylarCariprazine Hcl21$32,417
EliquisApixaban32$27,066
MounjaroTirzepatide11$21,491
BelsomraSuvorexant44$18,378
CreonLipase/Protease/Amylase11$16,578
Breo ElliptaFluticasone/Vilanterol12$9,470
Atorvastatin Calcium271$3,374
Pregabalin54$2,758
Diclofenac Sodium97$2,090
Gabapentin135$1,772

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$223$138,92277 claims
Boehringer IngelheimJardiance$15$63,57944 claims
Lilly USA, LLCTrulicity, Mounjaro$119$60,61229 claims
AbbVieVraylar, Creon, Synthroid$80$49,73347 claims
GSKTrelegy Ellipta, Breo Ellipta$45$47,03643 claims
AstraZenecaFarxiga$57$46,08532 claims
PfizerEliquis$49$27,06632 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$69789 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 292 adult health providers in South Carolina.

Other adult health in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →